US20210187172A1 - Systems and methods for managing reduced pressure at a plurality of wound sites - Google Patents
Systems and methods for managing reduced pressure at a plurality of wound sites Download PDFInfo
- Publication number
- US20210187172A1 US20210187172A1 US17/165,263 US202117165263A US2021187172A1 US 20210187172 A1 US20210187172 A1 US 20210187172A1 US 202117165263 A US202117165263 A US 202117165263A US 2021187172 A1 US2021187172 A1 US 2021187172A1
- Authority
- US
- United States
- Prior art keywords
- pressure
- reduced
- controller
- management device
- coupled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A61M1/0031—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/74—Suction control
-
- A61M1/0088—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/912—Connectors between dressing and drainage tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/918—Suction aspects of the dressing for multiple suction locations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/96—Suction control thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/96—Suction control thereof
- A61M1/966—Suction control thereof having a pressure sensor on or near the dressing
-
- A61M1/0027—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/73—Suction drainage systems comprising sensors or indicators for physical values
- A61M1/732—Visual indicating means for vacuum pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3344—Measuring or controlling pressure at the body treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/84—General characteristics of the apparatus for treating several patients simultaneously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
Definitions
- the present disclosure relates generally to medical treatment systems and, more particularly, but not by way of limitation, to systems, devices, and methods for managing reduced pressure at a plurality of wound sites.
- systems and methods are presented for providing reduced pressure to and monitoring pressure at a plurality of tissue sites using a plurality of pressure management devices.
- the pressure management devices are associated with a plurality of sensing conduits that fluidly couple the pressure management devices and the plurality of tissue sites.
- a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes a reduced-pressure source for providing reduced pressure, a plurality of reduced-pressure delivery conduits fluidly coupled to the reduced-pressure source, a plurality of reduced-pressure dressings fluidly coupled to the plurality of reduced-pressure delivery conduits in a one-to-one fashion, a plurality of pressure management devices, and a plurality of a sensing conduits fluidly coupled to the plurality of pressure management devices in a one-to-one fashion.
- Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing.
- Each pressure management device of the plurality of pressure management devices may include a controller, a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in an associated sensing conduit.
- a method for managing reduced pressure at a plurality of tissue sites undergoing reduced pressure treatment on a patient includes providing a reduced-pressure source, fluidly coupling a plurality of reduced-pressure delivery conduits to the reduced-pressure source, disposing a plurality of reduced-pressure dressings proximate to the plurality of tissue sites, fluidly coupling the plurality of reduced-pressure dressings to the plurality of reduced-pressure delivery conduits in a one-to-one fashion, providing a plurality of pressure management devices, and fluidly coupling a plurality of a sensing conduits to the plurality of pressure management devices in a one-to-one fashion.
- Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing.
- Each pressure management device of the plurality of pressure management devices may include a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in the associated sensing conduit.
- a method of manufacturing a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes providing a reduced-pressure source for providing reduced pressure, providing a plurality of reduced-pressure delivery conduits, fluidly coupling the plurality of reduced-pressure delivery conduits to the reduced-pressure source, providing a plurality of reduced-pressure dressings, providing plurality of pressure management devices, providing a plurality of a sensing conduits, and fluidly coupling the plurality of pressure management devices in a one-to-one fashion to the plurality of sensing conduits.
- Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing.
- Each pressure management device of the plurality of pressure management devices may include a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in an associated sensing conduit.
- a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes a reduced-pressure source for providing reduced pressure, a pressure management module, a first conduit fluidly coupled between the reduced-pressure source and the pressure management module, a plurality of reduced-pressure delivery conduits fluidly coupled between the pressure management module and a plurality of reduced-pressure dressings.
- the plurality of reduced-pressure dressings are coupled to the plurality of reduced-pressure delivery conduits in a one-to-one fashion.
- the system further includes a plurality of a sensing conduits fluidly coupled to the pressure management module.
- Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing.
- the pressure management module comprises a plurality of pressure management devices.
- Each pressure management device of the plurality of pressure management devices may include a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in an associated sensing conduit.
- a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes a reduced-pressure source for providing reduced pressure and a first plurality of reduced-pressure delivery conduits fluidly coupled to the reduced-pressure source.
- Each reduced-pressure delivery conduit of the first plurality of reduced-pressure delivery conduits has a first end and a second end.
- the second end of each of the first plurality of reduced-pressure delivery conduits has a first pressure-management connector coupled thereto.
- the system further includes a second plurality of reduced-pressure delivery conduits, each having a first end and a second end.
- the first end of the second plurality of reduced-pressure delivery conduits has a second pressure-management connector.
- the system further includes a plurality of reduced-pressure dressings fluidly coupled to the second plurality of reduced-pressure delivery conduits in a one-to-one fashion.
- the first pressure management connector of the plurality of reduced-pressure conduits is coupled to the second pressure-management connector of the second plurality of reduced-pressure in a one-to-one fashion.
- the first pressure management connector and second management connector couple to form a pressure management device, whereby the first pressure management connectors and the second pressure management connectors form a plurality of pressure management devices.
- Each reduced-pressure dressing has one of the second reduced-pressure delivery conduits associated with the reduced-pressure dressing.
- Each pressure management device of the plurality of pressure management devices includes a controller, a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the first plurality of reduced-pressure conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists at the associated sensing conduit.
- FIG. 1 is a schematic diagram, with a portion shown in cross section, of an illustrative, non-limiting embodiment of a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient;
- FIG. 2 is a schematic diagram of a portion of an illustrative embodiment of a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient showing an illustrative, non-limiting configuration of a pressure management device;
- FIG. 3 is a schematic, elevation view of an illustrative embodiment of an integral module formed from a plurality of pressure management devices
- FIG. 4 is a schematic, elevation view of an illustrative embodiment of an integral module that involves a conduit delivering reduced pressure that is split to provide reduced pressure to a plurality of reduced-pressure delivery conduits;
- FIG. 5 is a schematic, perspective view, with a portion shown as a diagram and a portion as a cross section, of another illustrative embodiment of a portion of a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient.
- Reduced pressure provided to tissue sites encourages healing at those tissue sites.
- multiple conduits may be used to deliver reduced pressure.
- a single reduced pressure source may be used with the multiple conduits branched off one conduit.
- Pressure monitoring is currently located in existing reduced-pressure sources and only one conduit communicates pressure to the reduced-pressure source. If only one conduit, which is associated with one tissue site, is monitored, as is the case when monitoring is done at the reduced-pressure source alone, pressure at other tissue sites may be unmonitored. This means that the pressure at the different tissue sites may vary greatly and yet go unnoticed. This, in turn, may cause a detrimental result in some situations.
- each tissue site of the plurality of tissue sites is monitored, and issues with reduced pressure delivery may be identified and addressed.
- An illustrative embodiment of a system 100 is presented that includes, among other things, pressure monitoring at multiple tissue sites.
- tissue sites 102 may comprise a single extended tissue site or wound or may be discrete wound sites or tissue sites.
- the tissue sites 102 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, or any other tissue. Unless otherwise indicated, as used throughout this document, “or” does not require mutual exclusivity. Treatment of the tissue sites 102 may include removal of fluids, e.g., exudate or ascites.
- the plurality of reduced-pressure dressings 106 in the illustrative embodiment of FIG. 1 is shown with a first reduced-pressure dressing 108 and a second reduced-pressure dressing 110 .
- the plurality of reduced-pressure dressings 106 may include any structure suitable for providing reduced pressure to a tissue site and removing fluids.
- the first reduced-pressure dressing 108 includes a manifold 112 that is disposed proximate to one of the tissue sites 102 with which the manifold 112 is associated.
- the manifold 112 is covered with a sealing member 114 , which may include an attachment device 116 , that creates a fluid seal.
- a fluid seal is a seal adequate to maintain reduced pressure at a desired tissue site given the particular reduced-pressure source or subsystem involved.
- the sealing member 114 which may include the attachment device 116 , creates a sealed space 118 in which the manifold 112 may reside.
- a reduced-pressure interface 120 may be placed through an aperture (not shown) and the sealing member 114 to provide reduced pressure into the sealed space 118 and in particular to the manifold 112 .
- the reduced pressure interface 120 may be a T.R.A.C.® Pad or Sensa T.R.A.C.® Pad available from KCI of San Antonio, Tex.
- the reduced-pressure interface 120 delivers the reduced pressure to the sealed space 118 .
- the second reduced-pressure dressing 110 is analogous to the first reduced-pressure dressing 108 .
- a manifold is generally a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from a tissue site, e.g., tissue site 102 .
- the manifold 112 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from the tissue site 102 around the manifold 112 .
- the flow channels or pathways are interconnected to improve distribution of fluids provided or removed from the tissue site 102 .
- the manifold 112 comprises one or more of the following: a biocompatible material that is capable of being placed in contact with the tissue site 102 and distributing reduced pressure to the tissue site 102 ; devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels; material that may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application; foam with interconnected cells; polyurethane; open-cell, reticulated foam such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Tex.; bioresorbable material; or scaffold material.
- a biocompatible material that is capable of being placed in contact with the tissue site 102 and distributing reduced pressure to the tissue site 102 ; devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections,
- the manifold 112 may also be used to distribute fluids such as medications, antibacterials, growth factors, and various solutions to the tissue site 102 .
- Other layers may be included in or on the manifold 112 , such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials.
- the manifold 112 may be constructed from bioresorbable materials that do not have to be removed from a patient's body following use of the reduced-pressure dressing 108 , 110 .
- Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA).
- the polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones.
- the manifold 112 may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with the manifold 112 to promote cell-growth.
- a scaffold is a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth.
- Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials.
- the sealing member 114 may be any material that provides a fluid seal.
- the sealing member 114 may, for example, be an impermeable or semi-permeable, elastomeric material.
- elastomers may include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, and silicones.
- Additional, specific examples of sealing member materials include a silicone drape, 3M Tegaderm® drape, polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif.
- the attachment device 116 may be used to hold the sealing member 114 against the patient's epidermis 111 or another layer, such as a gasket or additional sealing member, or another location.
- the attachment device 116 may take numerous forms.
- the attachment device 116 may be a medically acceptable, pressure-sensitive adhesive that extends about a periphery of the sealing member 114 .
- the reduced-pressure dressings 106 provide reduced pressure to the tissue sites 102 .
- Reduced pressure is generally a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure at the tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures.
- the reduced pressure delivered may be constant or varied (patterned or random) and may be delivered continuously or intermittently. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure applied to the tissue site may be more than the pressure normally associated with a complete vacuum. Consistent with the use herein, an increase in reduced pressure or vacuum pressure typically refers to a relative reduction in absolute pressure.
- a plurality of reduced-pressure delivery conduits 122 may be fluidly coupled to a reduced-pressure source 124 .
- the reduced-pressure delivery conduits 122 may be conduits for carrying reduced pressure and removing liquids alone or may be combined with one or more lumens for sensing pressure and providing a vent or a purge.
- a distinct plurality of sensing conduits 126 , or lumens is shown associated with the plurality of reduced-pressure delivery conduits 122 , but it should be understood that the sensing conduits 126 may be incorporated into the plurality of reduced-pressure delivery conduits 122 as a lumen in a multi-lumen conduit.
- the reduced-pressure source 124 provides reduced pressure.
- the reduced-pressure source 124 may be any device or source for supplying a reduced pressure, such as a vacuum pump, wall suction, micro-pump, or other source. If the reduced-pressure source 124 is a micro-pump, the micro-pump may be directly coupled to the plurality of management devices 128 . While the amount and nature of reduced pressure applied to a tissue site will typically vary according to the application, the reduced pressure will typically be between ⁇ 5 mm Hg ( ⁇ 667 Pa) and ⁇ 500 mm Hg ( ⁇ 66.7 kPa) and more typically between ⁇ 75 mm Hg ( ⁇ 9.9 kPa) and ⁇ 300 mm Hg ( ⁇ 39.9 kPa).
- the pressure may be ⁇ 12, ⁇ 12.5, ⁇ 13, ⁇ 14, ⁇ 14.5, ⁇ 15, ⁇ 15.5, ⁇ 16, ⁇ 16.5, ⁇ 17, ⁇ 17.5, ⁇ 18, ⁇ 18.5, ⁇ 19, ⁇ 19.5, ⁇ 20, ⁇ 20.5, ⁇ 21, ⁇ 21.5, ⁇ 22, ⁇ 22.5, ⁇ 23, ⁇ 23.5, ⁇ 24, ⁇ 24.5, ⁇ 25, ⁇ 25.5, ⁇ 26, ⁇ 26.5 kPa or another pressure.
- the plurality of pressure management devices 128 may be coupled to the plurality of reduced-pressure delivery conduits 122 and fluidly coupled to the plurality of sensing conduits 126 .
- the plurality of pressure management devices 128 may include, for example, a first pressure management device 130 and a second pressure management device 132 .
- Each of the plurality of pressure management devices 128 may include a housing 134 .
- the housing 134 may include a visual indicator 136 that may include indicators such as pressure disruption or caution symbol 138 and a touch mute button 140 .
- a manual power switch 142 may also be included on the housing 134 or on the visual indicator 136 .
- Each housing 134 may include a first portion 144 and a second portion 146 or edge.
- a first coupling member 148 which may include two components, may be coupled to the first portion 144 .
- a second coupling member 150 may be formed on the second portion 146 .
- the first coupling member 148 and the second coupling member 150 are sized and configured to couple with one another either fixedley or releasably.
- the optional coupling members 148 , 150 allow the plurality of pressure management devices 128 to be combined to form an integral module, i.e., a single unit.
- Other techniques and devices e.g., fasteners or clips, may be used to couple the pressure management devices 128 .
- the system 100 for managing reduced pressure at the plurality of tissue sites 102 is presented in diagram form with only the first pressure management device 130 of the plurality of pressure management devices 128 shown. It should be understood that any number of additional pressure management devices 128 may be combined as part of the system 100 . Additional aspects of the first pressure management device 130 may be explained in more detail with reference to FIG. 2 .
- the first pressure management device 130 is fluidly coupled to one of the plurality of sensing conduits 126 , and the sensing conduit 126 is fluidly coupled to a force transducer 152 (or pressure gauge) within the first pressure management device 130 .
- the force transducer 152 is able to develop a signal, e.g., an electrical signal, that indicates the pressure within the sensing conduit 126 or is otherwise able to detect various thresholds of pressure.
- the force transducer 152 is coupled at 154 to a controller 156 .
- the controller 156 may be a printed wire assembly (PWA) or an application specific integrated circuit (ASIC), a microprocessor with associated memory, or other controller device.
- PWA printed wire assembly
- ASIC application specific integrated circuit
- the controller 156 is able to thus monitor the pressure within the sensing conduit 126 and thereby to monitor pressure proximate to the tissue site 102 .
- the controller 156 receives power from a power unit 158 , such as a battery or other source of electrical power.
- the power unit 158 is coupled at 159 to the controller 156 .
- the controller 156 may activate or modify an indicator, such as an audible indicator 160 (or alarm) or a visual indicator 162 .
- the audible indicator 160 is shown coupled at 161 to the controller 156 .
- the visual indicator 162 is shown coupled at 163 to the controller 156 .
- a mute switch or button 164 may be associated with the controller 156 and is shown coupled at 166 .
- the mute switch 164 may allow a user to silence the audible indicator 160 .
- Other user interfaces may be coupled to the controller 156 to control other aspects of the first pressure management device 130 .
- a portion of the reduced-pressure delivery conduit 122 may extend through the first pressure management device 130 , and an activation sensor or transducer 168 may be fluidly coupled to the reduced-pressure delivery conduit 122 .
- the activation sensor 168 can detect the presence of reduced pressure and provide a signal 170 to the controller 156 .
- the controller 156 may compare the pressure delivered through the reduced-pressure delivery conduit 122 with the sensing pressure in the sensing conduit 126 to make certain determinations concerning performance and may also use the signal from the activation sensor 168 to continue to run controller 156 and other aspects of the first pressure management device 130 .
- a user may apply the plurality of reduced-pressure dressings 106 to the plurality of tissue sites 102 .
- the manifold 112 of the first reduced-pressure dressing 108 may be placed against the tissue site 102 and then be covered by the sealing member 114 to create the sealed space 118 .
- a reduced pressure interface 120 if not already installed, may be installed to provide reduced pressure to the sealed space 118 or otherwise to the manifold 112 .
- Other reduced-pressure dressings may be applied to each tissue site 102 for which treatment is desired.
- the plurality of reduced-pressure delivery conduits 122 may be fluidly coupled to the reduced-pressure source 124 in a one-to-one fashion.
- the reduced-pressure source 124 may have a first conduit 172 ( FIG. 1 ) that goes to a branching member or splitter 174 that fluidly couples the plurality of reduced-pressure delivery conduits 122 to the reduced-pressure source 124 .
- the plurality of sensing conduits 126 are fluidly coupled to the plurality of pressure management devices 128 .
- the reduced-pressure source 124 is activated and begins to deliver reduced pressure to the plurality of reduced-pressure dressings 106 .
- the plurality of pressure management devices 128 may be activated either automatically by the activation sensors 168 or manually by the user using an interface such as power switch 142 .
- reduced pressure is delivered to the tissue sites 102 and is monitored for each tissue site 102 . If there is a problem with the reduced pressure delivery at a tissue site 102 as sensed by one of the plurality of sensing conduits 126 , the pressure management device 128 associated with that particular sensing conduit of the plurality of sensing conduits 126 will sense the inadequate pressure via the associated force transducer 152 .
- the controller 156 which monitors the force transducer 152 , will then provide an indication using the audible indicator 160 or the visual indicator 162 .
- the user may then identify which reduced-pressure dressing of the plurality of reduced-pressure dressings 106 is having the difficulty. Corrective action may then be readily taken.
- the plurality of pressure management devices 128 may be coupled using the first coupling members 148 and the second coupling members 150 to form an integral module 176 .
- the integral module 176 provides for more convenient movement by the user and may also be more aesthetic.
- an illustrative embodiment of an integral module 176 or pressure management module 176 is presented that is analogous in most respects to the integrated module 176 shown in FIG. 3 . Accordingly, some parts are labeled but not further described here. There are, however, two main differences. First, the integrated module 176 of FIG. 4 may be manufactured with three otherwise independent pressure management devices is a single housing 178 . Second, and related, the integrated pressure management module 176 functions as a junction or branching member or splitter to receive reduced pressure from a first conduit 172 from a reduced-pressure source and to provide reduced pressure to each of the plurality of pressure management devices 128 for delivery through a plurality of reduced-pressure delivery conduits 122 .
- At least one reduced-pressure delivery conduit 122 may be a sensing lumen that provides pressure for sensing purposes to the reduced-pressure source, e.g., reduced-pressure source 124 in FIG. 1 .
- the reduced pressure delivered by reduced-pressure source 124 may be at a reduced pressure greater (more negative on an absolute pressure scale) than required anywhere in the system 100 and then stepped down to the desired pressure at various locations.
- a pressure regulating valve 182 may be provided to adjust the reduced pressure delivered from the reduced-pressure source 124 to the specific pressure desired for a particular tissue site 102 associated with that particular pressure management device.
- the pressure regulating valve 182 may have an adjustment control 184 for setting the desired pressure.
- a single reduced-pressure source 124 may be used that provides relatively higher reduced pressure (for example, but not by way of limitation, ⁇ 200 mm Hg) and then adjusted by the pressure regulating valve 182 to a first desired pressure (e.g., but not by way of limitation, to ⁇ 150 mm Hg) and delivered to a tissue site from which a graft has been taken.
- the system 100 also provides reduced pressure to a reduced-pressure dressing at the tissue site where the graft has been placed and may do so at a second desired pressure that is relatively less than the first desired pressure (e.g., but not by way of limitation, ⁇ 50 mm Hg).
- the controller 156 may control the adjustment control 184 .
- the desired pressure may be set by a user using a user interface to the controller 156 .
- an illustrative, non-limiting system 200 for managing reduced pressure at a plurality of tissue sites, e.g., tissue site 202 , undergoing reduced pressure treatment on a patient 204 is presented.
- the system 200 is analogous in many respects to the system 100 of FIG. 1 . While only one reduced-pressure dressing 208 and one pressure management device 228 is shown, it should be understand that the system 200 contemplates a plurality of each.
- the plurality of reduced-pressure dressings, such as reduced-pressure dressing 208 is placed on the tissue sites, e.g., tissue site 202 .
- a reduced-pressure interface 220 may be used to provide reduced pressure to a sealed space 218 that contains a manifold 212 and also allows for sensing of the pressure in the sealed space 218 .
- a reduced-pressure source 224 delivers reduced pressure to a first plurality of reduced-pressure delivery conduits 223 .
- a first conduit 272 may be used to deliver the reduced pressure to one or more splitters 274 or distributors that are fluidly coupled to the first plurality of reduced-pressure delivery conduits 223 .
- Each of the first reduced-pressure delivery conduits 223 has a first end 225 and a second end 227 . Coupled to the second end 227 of each of the first reduced-pressure delivery conduits 223 is a first pressure management connector 286 .
- a second pressure management connector 288 is releasably coupled to the first pressure management connector 286 to form a pressure management device 228 .
- a second plurality of reduced-pressure delivery conduits 290 may be used to fluidly couple the reduced-pressure interface 220 to the associated second pressure management connector 288 for each reduced-pressure dressing.
- Each of the second plurality of reduced-pressure delivery conduits 290 has a first end 292 and a second end 294 .
- the second pressure management connector 288 is coupled to the first end 292 of the associated conduit of the second plurality of reduced-pressure conduits 290 .
- Each pressure management device 228 created by coupling the first pressure management connector 286 and the second pressure management connector 288 provides both a fluid coupling and may also function analogously to the pressure management devices 128 of FIGS. 1-3 with respect to monitoring and control.
- the pressure management devices 228 provide a quick connection and also readily allow for one portion, e.g., the first pressure management connector 286 , to be reused and for another portion, e.g., the second pressure management connector 288 , to be discarded after use. Physically coupling the connectors 286 , 288 may also provide an electrical connection between the connectors 286 , 288 .
- various components of the first pressure management device 130 may be associated with either of the connectors 286 , 288 of the pressure management device 228 .
- the audible indicator 160 and visual indicator 162 may be associated with the first pressure management connector 286 .
- the controller 156 , power unit 158 , mute switch 164 , and force transducer 152 may be associated with the second pressure management connector 288 .
- Various combinations and permutations of the components may be associated with the two connectors 286 , 288 .
- the pressure regulating valve 182 may also be associated with the second pressure management connector 288 .
- Coupled includes coupling via a separate object and includes direct coupling.
- the term “coupled” also encompasses two or more components that are continuous with one another by virtue of each of the components being formed from the same piece of material.
- the term “coupled” may include chemical, such as via a chemical bond, mechanical, thermal, or electrical coupling.
- Fluid coupling means that fluid may be in communication between the designated parts or locations.
- the pressure management device may have no electronics and may use a physical device to monitor pressure and to indicate inadequate pressure.
- a pop-up pressure valve may be associated with each sensing lumen that is compressed under adequate reduced pressure, but expands and is visible when inadequate reduced pressure exists.
- the reduced-pressure source may be a monitored system that monitors one tissue site from which one conduit is fluidly coupled, and the pressure management devices may be added to the additional conduits associated with additional tissue sites.
- an integral module 176 has a plurality of pressure management devices 128 similar to those presented in FIG. 4 , but with only one controller (not explicitly shown) for the integral module 176 .
- the force transducers associated with each pressure management device 128 are coupled to the one controller for the integral module 176 .
Abstract
Systems and methods are presented for providing reduced pressure to and monitoring pressure at a plurality of tissue sites using a plurality of pressure management devices. The pressure management devices are associated with a plurality of sensing conduits that fluidly couple the pressure management devices and the plurality of tissue sites. Other systems, methods, and devices are disclosed.
Description
- This application is a Divisional of U.S. patent application Ser. No. 15/156,997, filed May 17, 2016, which is a Divisional of U.S. patent application Ser. No. 13/292,926, filed Nov. 9, 2011, now U.S. Pat. No. 9,364,591, which claims the benefit, under 35 USC § 119(e), of the filing of U.S. Provisional Patent Application Ser. No. 61/414,718, entitled “Systems and Methods for Managing Reduced Pressure at a Plurality of Wound Sites,” filed Nov. 17, 2010, which are incorporated herein by reference for all purposes.
- The present disclosure relates generally to medical treatment systems and, more particularly, but not by way of limitation, to systems, devices, and methods for managing reduced pressure at a plurality of wound sites.
- Clinical studies and practice have shown that providing a reduced pressure in proximity to a tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as “negative pressure wound therapy,” “reduced pressure therapy,” or “vacuum therapy”) provides a number of benefits, which may include faster healing and increased formulation of granulation tissue. Typically, when applied to open wounds, reduced pressure is applied to tissue through a porous pad or other manifold device. The porous pad contains cells or pores that are capable of distributing reduced pressure to the tissue and channeling fluids that are drawn from the tissue. At times, a patient may have a large wound requiring treatment at numerous sites or has a plurality of tissue sites requiring treatment.
- According to some illustrative embodiments, systems and methods are presented for providing reduced pressure to and monitoring pressure at a plurality of tissue sites using a plurality of pressure management devices. The pressure management devices are associated with a plurality of sensing conduits that fluidly couple the pressure management devices and the plurality of tissue sites.
- According to an illustrative embodiment, a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes a reduced-pressure source for providing reduced pressure, a plurality of reduced-pressure delivery conduits fluidly coupled to the reduced-pressure source, a plurality of reduced-pressure dressings fluidly coupled to the plurality of reduced-pressure delivery conduits in a one-to-one fashion, a plurality of pressure management devices, and a plurality of a sensing conduits fluidly coupled to the plurality of pressure management devices in a one-to-one fashion. Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing. Each pressure management device of the plurality of pressure management devices may include a controller, a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in an associated sensing conduit.
- According to another illustrative embodiment, a method for managing reduced pressure at a plurality of tissue sites undergoing reduced pressure treatment on a patient includes providing a reduced-pressure source, fluidly coupling a plurality of reduced-pressure delivery conduits to the reduced-pressure source, disposing a plurality of reduced-pressure dressings proximate to the plurality of tissue sites, fluidly coupling the plurality of reduced-pressure dressings to the plurality of reduced-pressure delivery conduits in a one-to-one fashion, providing a plurality of pressure management devices, and fluidly coupling a plurality of a sensing conduits to the plurality of pressure management devices in a one-to-one fashion. Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing. Each pressure management device of the plurality of pressure management devices may include a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in the associated sensing conduit.
- According to another illustrative embodiment, a method of manufacturing a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes providing a reduced-pressure source for providing reduced pressure, providing a plurality of reduced-pressure delivery conduits, fluidly coupling the plurality of reduced-pressure delivery conduits to the reduced-pressure source, providing a plurality of reduced-pressure dressings, providing plurality of pressure management devices, providing a plurality of a sensing conduits, and fluidly coupling the plurality of pressure management devices in a one-to-one fashion to the plurality of sensing conduits. Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing. Each pressure management device of the plurality of pressure management devices may include a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in an associated sensing conduit.
- According to another illustrative embodiment, a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes a reduced-pressure source for providing reduced pressure, a pressure management module, a first conduit fluidly coupled between the reduced-pressure source and the pressure management module, a plurality of reduced-pressure delivery conduits fluidly coupled between the pressure management module and a plurality of reduced-pressure dressings. The plurality of reduced-pressure dressings are coupled to the plurality of reduced-pressure delivery conduits in a one-to-one fashion. The system further includes a plurality of a sensing conduits fluidly coupled to the pressure management module. Each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing. The pressure management module comprises a plurality of pressure management devices. Each pressure management device of the plurality of pressure management devices may include a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists in an associated sensing conduit.
- According to another illustrative embodiment, a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient includes a reduced-pressure source for providing reduced pressure and a first plurality of reduced-pressure delivery conduits fluidly coupled to the reduced-pressure source. Each reduced-pressure delivery conduit of the first plurality of reduced-pressure delivery conduits has a first end and a second end. The second end of each of the first plurality of reduced-pressure delivery conduits has a first pressure-management connector coupled thereto. The system further includes a second plurality of reduced-pressure delivery conduits, each having a first end and a second end. The first end of the second plurality of reduced-pressure delivery conduits has a second pressure-management connector. The system further includes a plurality of reduced-pressure dressings fluidly coupled to the second plurality of reduced-pressure delivery conduits in a one-to-one fashion. The first pressure management connector of the plurality of reduced-pressure conduits is coupled to the second pressure-management connector of the second plurality of reduced-pressure in a one-to-one fashion. The first pressure management connector and second management connector couple to form a pressure management device, whereby the first pressure management connectors and the second pressure management connectors form a plurality of pressure management devices. Each reduced-pressure dressing has one of the second reduced-pressure delivery conduits associated with the reduced-pressure dressing. Each pressure management device of the plurality of pressure management devices includes a controller, a power unit electrically coupled to the controller for providing power to the controller, a force transducer associated with a sensing conduit of the first plurality of reduced-pressure conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and an indicator coupled to the controller for indicating when insufficient pressure exists at the associated sensing conduit.
- Other features and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
-
FIG. 1 is a schematic diagram, with a portion shown in cross section, of an illustrative, non-limiting embodiment of a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient; -
FIG. 2 is a schematic diagram of a portion of an illustrative embodiment of a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient showing an illustrative, non-limiting configuration of a pressure management device; -
FIG. 3 is a schematic, elevation view of an illustrative embodiment of an integral module formed from a plurality of pressure management devices; -
FIG. 4 is a schematic, elevation view of an illustrative embodiment of an integral module that involves a conduit delivering reduced pressure that is split to provide reduced pressure to a plurality of reduced-pressure delivery conduits; and -
FIG. 5 is a schematic, perspective view, with a portion shown as a diagram and a portion as a cross section, of another illustrative embodiment of a portion of a system for managing reduced pressure at multiple tissue sites undergoing reduced pressure treatment on a patient. - In the following detailed description of the illustrative, non-limiting embodiments, reference is made to the accompanying drawings that form a part hereof. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the illustrative embodiments are defined only by the appended claims.
- Reduced pressure provided to tissue sites encourages healing at those tissue sites. To accommodate multiple tissue sites, e.g., multiple wounds on a patient, multiple conduits may be used to deliver reduced pressure. A single reduced pressure source may be used with the multiple conduits branched off one conduit. Pressure monitoring is currently located in existing reduced-pressure sources and only one conduit communicates pressure to the reduced-pressure source. If only one conduit, which is associated with one tissue site, is monitored, as is the case when monitoring is done at the reduced-pressure source alone, pressure at other tissue sites may be unmonitored. This means that the pressure at the different tissue sites may vary greatly and yet go unnoticed. This, in turn, may cause a detrimental result in some situations. For example, if a graft does not receive reduced pressure for two hours, the graft may not take. With the current system, each tissue site of the plurality of tissue sites is monitored, and issues with reduced pressure delivery may be identified and addressed. An illustrative embodiment of a
system 100 is presented that includes, among other things, pressure monitoring at multiple tissue sites. - Referring now to the drawings and initially to
FIG. 1 , thesystem 100 for managing reduced pressure at a plurality oftissue sites 102 that are undergoing reduced pressure treatment on apatient 104 is presented. A plurality of reduced-pressure dressings 106 are used with the plurality oftissue sites 102. Typically, one of the plurality of reduced-pressure dressings 106 is associated with one of the plurality oftissue sites 102. Thetissue sites 102 may comprise a single extended tissue site or wound or may be discrete wound sites or tissue sites. Each of thetissue sites 102 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, or any other tissue. Unless otherwise indicated, as used throughout this document, “or” does not require mutual exclusivity. Treatment of thetissue sites 102 may include removal of fluids, e.g., exudate or ascites. - The plurality of reduced-
pressure dressings 106 in the illustrative embodiment ofFIG. 1 is shown with a first reduced-pressure dressing 108 and a second reduced-pressure dressing 110. The plurality of reduced-pressure dressings 106 may include any structure suitable for providing reduced pressure to a tissue site and removing fluids. For example, in one illustrative embodiment, the first reduced-pressure dressing 108 includes a manifold 112 that is disposed proximate to one of thetissue sites 102 with which themanifold 112 is associated. The manifold 112 is covered with a sealingmember 114, which may include anattachment device 116, that creates a fluid seal. A fluid seal is a seal adequate to maintain reduced pressure at a desired tissue site given the particular reduced-pressure source or subsystem involved. The sealingmember 114, which may include theattachment device 116, creates a sealedspace 118 in which the manifold 112 may reside. A reduced-pressure interface 120 may be placed through an aperture (not shown) and the sealingmember 114 to provide reduced pressure into the sealedspace 118 and in particular to themanifold 112. For example, the reducedpressure interface 120 may be a T.R.A.C.® Pad or Sensa T.R.A.C.® Pad available from KCI of San Antonio, Tex. The reduced-pressure interface 120 delivers the reduced pressure to the sealedspace 118. The second reduced-pressure dressing 110 is analogous to the first reduced-pressure dressing 108. - With respect to the manifold 112, a manifold is generally a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from a tissue site, e.g.,
tissue site 102. The manifold 112 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from thetissue site 102 around themanifold 112. In one illustrative embodiment, the flow channels or pathways are interconnected to improve distribution of fluids provided or removed from thetissue site 102. The manifold 112 comprises one or more of the following: a biocompatible material that is capable of being placed in contact with thetissue site 102 and distributing reduced pressure to thetissue site 102; devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels; material that may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application; foam with interconnected cells; polyurethane; open-cell, reticulated foam such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Tex.; bioresorbable material; or scaffold material. In some situations, the manifold 112 may also be used to distribute fluids such as medications, antibacterials, growth factors, and various solutions to thetissue site 102. Other layers may be included in or on the manifold 112, such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials. - In one illustrative embodiment, the manifold 112 may be constructed from bioresorbable materials that do not have to be removed from a patient's body following use of the reduced-pressure dressing 108, 110. Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA). The polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones. The manifold 112 may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with the manifold 112 to promote cell-growth. A scaffold is a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth. Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials.
- The sealing
member 114 may be any material that provides a fluid seal. The sealingmember 114 may, for example, be an impermeable or semi-permeable, elastomeric material. Examples of elastomers may include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, and silicones. Additional, specific examples of sealing member materials include a silicone drape, 3M Tegaderm® drape, polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif. - The
attachment device 116 may be used to hold the sealingmember 114 against the patient'sepidermis 111 or another layer, such as a gasket or additional sealing member, or another location. Theattachment device 116 may take numerous forms. For example, theattachment device 116 may be a medically acceptable, pressure-sensitive adhesive that extends about a periphery of the sealingmember 114. - The reduced-
pressure dressings 106 provide reduced pressure to thetissue sites 102. Reduced pressure is generally a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure at the tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures. The reduced pressure delivered may be constant or varied (patterned or random) and may be delivered continuously or intermittently. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure applied to the tissue site may be more than the pressure normally associated with a complete vacuum. Consistent with the use herein, an increase in reduced pressure or vacuum pressure typically refers to a relative reduction in absolute pressure. - A plurality of reduced-
pressure delivery conduits 122 may be fluidly coupled to a reduced-pressure source 124. The reduced-pressure delivery conduits 122 may be conduits for carrying reduced pressure and removing liquids alone or may be combined with one or more lumens for sensing pressure and providing a vent or a purge. For description purposes, a distinct plurality ofsensing conduits 126, or lumens, is shown associated with the plurality of reduced-pressure delivery conduits 122, but it should be understood that thesensing conduits 126 may be incorporated into the plurality of reduced-pressure delivery conduits 122 as a lumen in a multi-lumen conduit. - The reduced-
pressure source 124 provides reduced pressure. The reduced-pressure source 124 may be any device or source for supplying a reduced pressure, such as a vacuum pump, wall suction, micro-pump, or other source. If the reduced-pressure source 124 is a micro-pump, the micro-pump may be directly coupled to the plurality ofmanagement devices 128. While the amount and nature of reduced pressure applied to a tissue site will typically vary according to the application, the reduced pressure will typically be between −5 mm Hg (−667 Pa) and −500 mm Hg (−66.7 kPa) and more typically between −75 mm Hg (−9.9 kPa) and −300 mm Hg (−39.9 kPa). For example, and not by way of limitation, the pressure may be −12, −12.5, −13, −14, −14.5, −15, −15.5, −16, −16.5, −17, −17.5, −18, −18.5, −19, −19.5, −20, −20.5, −21, −21.5, −22, −22.5, −23, −23.5, −24, −24.5, −25, −25.5, −26, −26.5 kPa or another pressure. - The plurality of
pressure management devices 128 may be coupled to the plurality of reduced-pressure delivery conduits 122 and fluidly coupled to the plurality ofsensing conduits 126. The plurality ofpressure management devices 128 may include, for example, a firstpressure management device 130 and a secondpressure management device 132. Each of the plurality ofpressure management devices 128 may include ahousing 134. Thehousing 134 may include avisual indicator 136 that may include indicators such as pressure disruption orcaution symbol 138 and a touchmute button 140. Amanual power switch 142 may also be included on thehousing 134 or on thevisual indicator 136. Eachhousing 134 may include afirst portion 144 and asecond portion 146 or edge. Afirst coupling member 148, which may include two components, may be coupled to thefirst portion 144. Asecond coupling member 150 may be formed on thesecond portion 146. Thefirst coupling member 148 and thesecond coupling member 150 are sized and configured to couple with one another either fixedley or releasably. As described further below in connection withFIG. 3 , theoptional coupling members pressure management devices 128 to be combined to form an integral module, i.e., a single unit. Other techniques and devices, e.g., fasteners or clips, may be used to couple thepressure management devices 128. - Referring now primarily to
FIG. 2 , thesystem 100 for managing reduced pressure at the plurality oftissue sites 102 is presented in diagram form with only the firstpressure management device 130 of the plurality ofpressure management devices 128 shown. It should be understood that any number of additionalpressure management devices 128 may be combined as part of thesystem 100. Additional aspects of the firstpressure management device 130 may be explained in more detail with reference toFIG. 2 . - The first
pressure management device 130 is fluidly coupled to one of the plurality ofsensing conduits 126, and thesensing conduit 126 is fluidly coupled to a force transducer 152 (or pressure gauge) within the firstpressure management device 130. Theforce transducer 152 is able to develop a signal, e.g., an electrical signal, that indicates the pressure within thesensing conduit 126 or is otherwise able to detect various thresholds of pressure. Theforce transducer 152 is coupled at 154 to acontroller 156. Thecontroller 156 may be a printed wire assembly (PWA) or an application specific integrated circuit (ASIC), a microprocessor with associated memory, or other controller device. - The
controller 156 is able to thus monitor the pressure within thesensing conduit 126 and thereby to monitor pressure proximate to thetissue site 102. Thecontroller 156 receives power from apower unit 158, such as a battery or other source of electrical power. Thepower unit 158 is coupled at 159 to thecontroller 156. When thecontroller 156 determines that the reduced pressure within thesensing conduit 126 is inadequate (e.g., below a reduced-pressure threshold), such as may be caused by a leak in the reduced-pressure dressing associated with theparticular sensing conduit 126 or a blockage or other problem, thecontroller 156 may activate or modify an indicator, such as an audible indicator 160 (or alarm) or avisual indicator 162. Theaudible indicator 160 is shown coupled at 161 to thecontroller 156. Thevisual indicator 162 is shown coupled at 163 to thecontroller 156. A mute switch orbutton 164 may be associated with thecontroller 156 and is shown coupled at 166. Themute switch 164 may allow a user to silence theaudible indicator 160. Other user interfaces may be coupled to thecontroller 156 to control other aspects of the firstpressure management device 130. - A portion of the reduced-
pressure delivery conduit 122 may extend through the firstpressure management device 130, and an activation sensor ortransducer 168 may be fluidly coupled to the reduced-pressure delivery conduit 122. Theactivation sensor 168 can detect the presence of reduced pressure and provide asignal 170 to thecontroller 156. Thecontroller 156 may compare the pressure delivered through the reduced-pressure delivery conduit 122 with the sensing pressure in thesensing conduit 126 to make certain determinations concerning performance and may also use the signal from theactivation sensor 168 to continue to runcontroller 156 and other aspects of the firstpressure management device 130. - Referring now primarily to
FIGS. 1 and 2 , in operation, according to one illustrative embodiment, a user may apply the plurality of reduced-pressure dressings 106 to the plurality oftissue sites 102. For example, themanifold 112 of the first reduced-pressure dressing 108 may be placed against thetissue site 102 and then be covered by the sealingmember 114 to create the sealedspace 118. A reducedpressure interface 120, if not already installed, may be installed to provide reduced pressure to the sealedspace 118 or otherwise to themanifold 112. Other reduced-pressure dressings may be applied to eachtissue site 102 for which treatment is desired. - The plurality of reduced-
pressure delivery conduits 122 may be fluidly coupled to the reduced-pressure source 124 in a one-to-one fashion. In this regard, the reduced-pressure source 124 may have a first conduit 172 (FIG. 1 ) that goes to a branching member orsplitter 174 that fluidly couples the plurality of reduced-pressure delivery conduits 122 to the reduced-pressure source 124. The plurality ofsensing conduits 126 are fluidly coupled to the plurality ofpressure management devices 128. - The reduced-
pressure source 124 is activated and begins to deliver reduced pressure to the plurality of reduced-pressure dressings 106. The plurality ofpressure management devices 128 may be activated either automatically by theactivation sensors 168 or manually by the user using an interface such aspower switch 142. Thus, reduced pressure is delivered to thetissue sites 102 and is monitored for eachtissue site 102. If there is a problem with the reduced pressure delivery at atissue site 102 as sensed by one of the plurality ofsensing conduits 126, thepressure management device 128 associated with that particular sensing conduit of the plurality ofsensing conduits 126 will sense the inadequate pressure via the associatedforce transducer 152. Thecontroller 156, which monitors theforce transducer 152, will then provide an indication using theaudible indicator 160 or thevisual indicator 162. The user may then identify which reduced-pressure dressing of the plurality of reduced-pressure dressings 106 is having the difficulty. Corrective action may then be readily taken. - As shown in
FIG. 3 , the plurality ofpressure management devices 128 may be coupled using thefirst coupling members 148 and thesecond coupling members 150 to form anintegral module 176. Theintegral module 176 provides for more convenient movement by the user and may also be more aesthetic. - Referring now primarily to
FIG. 4 , an illustrative embodiment of anintegral module 176 orpressure management module 176 is presented that is analogous in most respects to theintegrated module 176 shown inFIG. 3 . Accordingly, some parts are labeled but not further described here. There are, however, two main differences. First, theintegrated module 176 ofFIG. 4 may be manufactured with three otherwise independent pressure management devices is asingle housing 178. Second, and related, the integratedpressure management module 176 functions as a junction or branching member or splitter to receive reduced pressure from afirst conduit 172 from a reduced-pressure source and to provide reduced pressure to each of the plurality ofpressure management devices 128 for delivery through a plurality of reduced-pressure delivery conduits 122. While not explicitly shown, associated with or formed as part of the reduced-pressure delivery conduits 122 is a plurality of pressure sensing lumens or conduits. The plurality of sensing lumens allows the plurality of pressure management devices to monitor pressure at a plurality of tissue sites. At least one reduced-pressure delivery conduit 122 may be a sensing lumen that provides pressure for sensing purposes to the reduced-pressure source, e.g., reduced-pressure source 124 inFIG. 1 . - Referring again primarily to
FIG. 2 , another illustrative embodiment ofsystem 100 will be presented. With respect to this embodiment ofsystem 100, the reduced pressure delivered by reduced-pressure source 124 may be at a reduced pressure greater (more negative on an absolute pressure scale) than required anywhere in thesystem 100 and then stepped down to the desired pressure at various locations. Thus, as an aspect of each of the plurality ofpressure management devices 128, apressure regulating valve 182 may be provided to adjust the reduced pressure delivered from the reduced-pressure source 124 to the specific pressure desired for aparticular tissue site 102 associated with that particular pressure management device. - The
pressure regulating valve 182 may have anadjustment control 184 for setting the desired pressure. Thus, as one example, a single reduced-pressure source 124 may be used that provides relatively higher reduced pressure (for example, but not by way of limitation, −200 mm Hg) and then adjusted by thepressure regulating valve 182 to a first desired pressure (e.g., but not by way of limitation, to −150 mm Hg) and delivered to a tissue site from which a graft has been taken. Thesystem 100 also provides reduced pressure to a reduced-pressure dressing at the tissue site where the graft has been placed and may do so at a second desired pressure that is relatively less than the first desired pressure (e.g., but not by way of limitation, −50 mm Hg). In another illustrative embodiment, thecontroller 156 may control theadjustment control 184. The desired pressure may be set by a user using a user interface to thecontroller 156. - Referring now primarily to
FIG. 5 , an illustrative,non-limiting system 200 for managing reduced pressure at a plurality of tissue sites, e.g.,tissue site 202, undergoing reduced pressure treatment on apatient 204 is presented. Thesystem 200 is analogous in many respects to thesystem 100 ofFIG. 1 . While only one reduced-pressure dressing 208 and onepressure management device 228 is shown, it should be understand that thesystem 200 contemplates a plurality of each. The plurality of reduced-pressure dressings, such as reduced-pressure dressing 208, is placed on the tissue sites, e.g.,tissue site 202. With each reduced-pressure dressing, a reduced-pressure interface 220 may be used to provide reduced pressure to a sealedspace 218 that contains amanifold 212 and also allows for sensing of the pressure in the sealedspace 218. - A reduced-
pressure source 224 delivers reduced pressure to a first plurality of reduced-pressure delivery conduits 223. Afirst conduit 272 may be used to deliver the reduced pressure to one ormore splitters 274 or distributors that are fluidly coupled to the first plurality of reduced-pressure delivery conduits 223. Each of the first reduced-pressure delivery conduits 223 has afirst end 225 and asecond end 227. Coupled to thesecond end 227 of each of the first reduced-pressure delivery conduits 223 is a firstpressure management connector 286. A secondpressure management connector 288 is releasably coupled to the firstpressure management connector 286 to form apressure management device 228. A second plurality of reduced-pressure delivery conduits 290 may be used to fluidly couple the reduced-pressure interface 220 to the associated secondpressure management connector 288 for each reduced-pressure dressing. Each of the second plurality of reduced-pressure delivery conduits 290 has afirst end 292 and asecond end 294. The secondpressure management connector 288 is coupled to thefirst end 292 of the associated conduit of the second plurality of reduced-pressure conduits 290. - Each
pressure management device 228 created by coupling the firstpressure management connector 286 and the secondpressure management connector 288 provides both a fluid coupling and may also function analogously to thepressure management devices 128 ofFIGS. 1-3 with respect to monitoring and control. Thepressure management devices 228 provide a quick connection and also readily allow for one portion, e.g., the firstpressure management connector 286, to be reused and for another portion, e.g., the secondpressure management connector 288, to be discarded after use. Physically coupling theconnectors connectors FIG. 2 again, various components of the firstpressure management device 130 may be associated with either of theconnectors pressure management device 228. - In one illustrative embodiment, the
audible indicator 160 andvisual indicator 162 may be associated with the firstpressure management connector 286. Thecontroller 156,power unit 158,mute switch 164, andforce transducer 152 may be associated with the secondpressure management connector 288. Various combinations and permutations of the components may be associated with the twoconnectors pressure regulating valve 182 may also be associated with the secondpressure management connector 288. - As used herein, the term “coupled” includes coupling via a separate object and includes direct coupling. The term “coupled” also encompasses two or more components that are continuous with one another by virtue of each of the components being formed from the same piece of material. Also, the term “coupled” may include chemical, such as via a chemical bond, mechanical, thermal, or electrical coupling. Fluid coupling means that fluid may be in communication between the designated parts or locations.
- In another illustrative embodiment, the pressure management device may have no electronics and may use a physical device to monitor pressure and to indicate inadequate pressure. For example, a pop-up pressure valve may be associated with each sensing lumen that is compressed under adequate reduced pressure, but expands and is visible when inadequate reduced pressure exists.
- The
pressure management devices 128 may be used with any reduced-pressure source, which may be any device for supplying a reduced pressure, such as a vacuum pump, wall suction, or other source. With the inclusion of apressure regulating valve 182, thepressure management devices 128 allow for a single reduced-pressure source to supply and monitor reduced pressure at different pressures at different tissue sites. - The reduced-pressure source may be a monitored system that monitors one tissue site from which one conduit is fluidly coupled, and the pressure management devices may be added to the additional conduits associated with additional tissue sites.
- Referring again generally to
FIGS. 1 and 4 , in another illustrative embodiment, asystem 100 for managing reduced pressure at a plurality oftissue sites 102 that are undergoing reduced pressure treatment on apatient 104 is presented. In this illustrative embodiment, anintegral module 176 has a plurality ofpressure management devices 128 similar to those presented inFIG. 4 , but with only one controller (not explicitly shown) for theintegral module 176. The force transducers associated with eachpressure management device 128 are coupled to the one controller for theintegral module 176. - Although the present invention and its advantages have been disclosed in the context of certain illustrative, non-limiting embodiments, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the invention as defined by the appended claims. It will be appreciated that any feature that is described in connection to any one embodiment may also be applicable to any other embodiment.
- It will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments. It will further be understood that reference to “an” item refers to one or more of those items.
- The steps of the methods described herein may be carried out in any suitable order, or simultaneously where appropriate.
- Where appropriate, aspects of any of the embodiments described above may be combined with aspects of any of the other embodiments described to form further examples having comparable or different properties and addressing the same or different problems.
- It will be understood that the above description of preferred embodiments is given by way of example only and that various modifications may be made by those skilled in the art. The above specification, examples and data provide a complete description of the structure and use of exemplary embodiments of the invention. Although various embodiments of the invention have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of the claims.
Claims (13)
1.-35. (canceled)
36. A system to manage reduced pressure for reduced pressure treatment, the system comprising:
a first pressure management device coupled to:
a reduced-pressure source and a first reduced-pressure dressing, and
a first sensing conduit in fluid communication with the first reduced-pressure dressing;
the first pressure management device comprising:
a first force transducer associated with the first sensing conduit and electrically coupled to a first controller to determine when a reduced-pressure threshold exists at a tissue site via the first sensing conduit, and
a first indicator configured to indicate when insufficient pressure exists in the first sensing conduit;
a second pressure management device coupled to:
the reduced-pressure source and a second reduced-pressure dressing, and
a second sensing conduit in fluid communication with the second reduced-pressure dressing; and
the second pressure management device comprising:
a second force transducer associated with the second sensing conduit and electrically coupled to a second controller to determine when a reduced-pressure threshold exists at a tissue site via the second sensing conduit, and
a second indicator configured to indicate when insufficient pressure exists in the second sensing conduit.
37. The system of claim 36 , wherein the first pressure management device further comprises a first activation sensor configured to operate the first controller when detecting a reduced pressure, and wherein the second pressure management device further comprises a second activation sensor configured to operate the second controller when detecting a reduced pressure.
38. The system of claim 37 , wherein the first activation sensor is fluidly coupled to a first reduced-pressure delivery conduit associated with the first pressure management device and electrically coupled to the first controller, and wherein the second activation sensor is fluidly coupled to a second reduced-pressure delivery conduit associated with the second pressure management device and electrically coupled to the second controller.
39. The system of claim 36 , wherein each of the first indicator and the second indicator are selected from a group of an audible indicator and a visual indicator.
40. The system of claim 36 , wherein each of the first pressure management device and the second pressure management device further comprises a muting switch.
41. The system of claim 36 , wherein each of the first pressure management device and the second pressure management device are coupled to form an integral module.
42. The system of claim 36 , wherein each of the first reduced-pressure dressing and the second reduced-pressure dressing comprises: a manifold for placing proximate to a tissue site, a sealing member for covering the manifold and tissue site to create a sealed space, and a reduced-pressure interface for providing reduced pressure to the sealed space.
43. The system of claim 36 , wherein at least the first pressure management device comprises:
a first coupling member coupled to a first portion of a housing of the first pressure management device,
a second coupling member coupled to a second portion of the housing of the first pressure management device, and
wherein the first coupling member is sized and configured to couple with another coupling member on another pressure management device to couple the first pressure management device into direct contact with another pressure management device.
44. A system for managing reduced pressure at a plurality of tissue sites undergoing reduced pressure treatment on a patient, the system comprising:
a reduced-pressure source for providing reduced pressure;
a first plurality of reduced-pressure delivery conduits fluidly coupled to the reduced-pressure source, each reduced-pressure delivery conduit of the first plurality of reduced-pressure delivery conduits having a first end and a second end, and wherein the second end has a first pressure-management connector;
a second plurality of reduced-pressure delivery conduits each having a first end and a second end, and wherein the first end has a second pressure-management connector;
a plurality of reduced-pressure dressings coupled to the second plurality of reduced-pressure delivery conduits in a one-to-one fashion;
wherein the first pressure-management connectors of the first plurality of reduced-pressure delivery conduits is coupled to the second pressure-management connectors of the second plurality of reduced-pressure delivery conduits in a one-to-one fashion, and wherein the first pressure-management connectors and second pressure-management connectors couple to form a plurality of pressure-management devices;
wherein each reduced-pressure dressing has one of the second reduced-pressure delivery conduits associated with the reduced-pressure dressing; and
wherein each pressure management device of the plurality of pressure management devices comprises:
a controller,
a power unit electrically coupled to the controller for providing power to the controller,
a force transducer associated with a sensing conduit of the first plurality of reduced-pressure delivery conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and
an indicator coupled to the controller for indicating when insufficient pressure exists at an associated sensing conduit.
45. The system of claim 44 , wherein for each pressure management device, the indicator is coupled to a first pressure-management connector of the first pressure-management connectors.
46. The system of claim 44 , wherein for each pressure management device, the indicator is coupled to a first pressure-management connector of the first pressure-management connectors and the controller, the power unit, and the force transducer are coupled to the second pressure-management connector of the second pressure-management connectors.
47. A method of manufacturing a system for managing reduced pressure at plurality of tissue sites undergoing reduced pressure treatment on a patient, the method comprising:
providing a reduced-pressure source for providing reduced pressure;
providing a plurality of reduced-pressure delivery conduits;
fluidly coupling the plurality of reduced-pressure delivery conduits to the reduced-pressure source;
providing a plurality of reduced-pressure dressings;
providing plurality of pressure management devices;
providing a plurality of sensing conduits;
fluidly coupling the plurality of pressure management devices in a one-to-one fashion to the plurality of sensing conduits;
wherein each reduced-pressure dressing has a sensing conduit of the plurality of sensing conduits and a reduced-pressure delivery conduit of the plurality of reduced-pressure delivery conduits associated with the reduced-pressure dressing; and
wherein each pressure management device of the plurality of pressure management devices comprises:
a controller,
a power unit electrically coupled to the controller for providing power to the controller,
a force transducer associated with a sensing conduit of the plurality of sensing conduits and electrically coupled to the controller for determining if a reduced-pressure threshold exists at a tissue site associated with the sensing conduit, and
an indicator coupled to the controller for indicating when insufficient pressure exists in an associated sensing conduit.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/165,263 US20210187172A1 (en) | 2010-11-17 | 2021-02-02 | Systems and methods for managing reduced pressure at a plurality of wound sites |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41471810P | 2010-11-17 | 2010-11-17 | |
US13/292,926 US9364591B2 (en) | 2010-11-17 | 2011-11-09 | Systems and methods for managing reduced pressure at a plurality of wound sites |
US15/156,997 US10940243B2 (en) | 2010-11-17 | 2016-05-17 | Systems and methods for managing reduced pressure at a plurality of wound sites |
US17/165,263 US20210187172A1 (en) | 2010-11-17 | 2021-02-02 | Systems and methods for managing reduced pressure at a plurality of wound sites |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/156,997 Division US10940243B2 (en) | 2010-11-17 | 2016-05-17 | Systems and methods for managing reduced pressure at a plurality of wound sites |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210187172A1 true US20210187172A1 (en) | 2021-06-24 |
Family
ID=44993950
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/292,926 Active 2034-10-18 US9364591B2 (en) | 2010-11-17 | 2011-11-09 | Systems and methods for managing reduced pressure at a plurality of wound sites |
US15/156,997 Active 2034-10-23 US10940243B2 (en) | 2010-11-17 | 2016-05-17 | Systems and methods for managing reduced pressure at a plurality of wound sites |
US17/165,263 Abandoned US20210187172A1 (en) | 2010-11-17 | 2021-02-02 | Systems and methods for managing reduced pressure at a plurality of wound sites |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/292,926 Active 2034-10-18 US9364591B2 (en) | 2010-11-17 | 2011-11-09 | Systems and methods for managing reduced pressure at a plurality of wound sites |
US15/156,997 Active 2034-10-23 US10940243B2 (en) | 2010-11-17 | 2016-05-17 | Systems and methods for managing reduced pressure at a plurality of wound sites |
Country Status (8)
Country | Link |
---|---|
US (3) | US9364591B2 (en) |
EP (4) | EP3295971B1 (en) |
JP (2) | JP6114194B2 (en) |
CN (1) | CN103189080B (en) |
AU (1) | AU2011329273B2 (en) |
CA (1) | CA2814873C (en) |
TW (1) | TW201225932A (en) |
WO (1) | WO2012067916A1 (en) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
US9681522B2 (en) | 2012-05-06 | 2017-06-13 | Lighting Science Group Corporation | Adaptive light system and associated methods |
US8743023B2 (en) | 2010-07-23 | 2014-06-03 | Biological Illumination, Llc | System for generating non-homogenous biologically-adjusted light and associated methods |
WO2012051278A1 (en) | 2010-10-12 | 2012-04-19 | Tanis Kevin J | Medical device |
US9364591B2 (en) * | 2010-11-17 | 2016-06-14 | Kci Licensing, Inc. | Systems and methods for managing reduced pressure at a plurality of wound sites |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
JP6078472B2 (en) | 2010-11-25 | 2017-02-08 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Compositions I-II and products and their use |
RU2756986C2 (en) | 2011-02-04 | 2021-10-08 | Юниверсити Оф Массачусетс | Wound closure device with the creation of negative pressure |
US9421132B2 (en) | 2011-02-04 | 2016-08-23 | University Of Massachusetts | Negative pressure wound closure device |
US8754832B2 (en) | 2011-05-15 | 2014-06-17 | Lighting Science Group Corporation | Lighting system for accenting regions of a layer and associated methods |
AU2012333210B2 (en) * | 2011-06-24 | 2017-01-19 | Solventum Intellectual Properties Company | Reduced-pressure dressings employing tissue-fixation elements |
AU2012340789B2 (en) | 2011-11-23 | 2017-05-04 | Solventum Intellectual Properties Company | Reduced-pressure systems, methods, and devices for simultaneously treating a plurality of tissue sites |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
JP6250571B2 (en) | 2012-03-12 | 2017-12-20 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Pressure reducing apparatus and method |
EP3470029A1 (en) | 2012-05-24 | 2019-04-17 | Smith & Nephew, Inc. | Devices for treating and closing wounds with negative pressure |
AU2013290346B2 (en) | 2012-07-16 | 2018-06-07 | Smith & Nephew, Inc. | Negative pressure wound closure device |
EP2895213B8 (en) * | 2012-09-12 | 2017-08-30 | KCI Licensing, Inc. | Systems for collecting exudates in reduced-pressure therapy |
US9744278B2 (en) | 2012-10-25 | 2017-08-29 | Kci Licensing, Inc. | Wound connection pad with pneumatic connection confirmation ability |
MX369065B (en) | 2013-03-13 | 2019-10-28 | Smith & Nephew Inc | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure. |
US9737649B2 (en) | 2013-03-14 | 2017-08-22 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
CA2902634C (en) | 2013-03-14 | 2023-01-10 | Smith & Nephew Inc. | Systems and methods for applying reduced pressure therapy |
AU2014229749B2 (en) | 2013-03-14 | 2018-09-20 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
US10695226B2 (en) | 2013-03-15 | 2020-06-30 | Smith & Nephew Plc | Wound dressing and method of treatment |
AU2014229777B2 (en) | 2013-03-15 | 2018-03-08 | Smith & Nephew Plc | Wound dressing and method of treatment |
US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
CA2918157A1 (en) | 2013-07-16 | 2015-01-22 | Smith & Nephew Plc | Apparatus for wound therapy |
US10155070B2 (en) | 2013-08-13 | 2018-12-18 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
CN105744918B (en) * | 2013-10-02 | 2020-11-20 | 凯希特许有限公司 | Disposable reduced pressure treatment system with electronic feedback |
CN103800993A (en) * | 2014-02-28 | 2014-05-21 | 昆山韦睿医疗科技有限公司 | Negative-pressure wound treatment equipment and system |
CA3179001A1 (en) | 2014-07-31 | 2016-02-04 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US10549016B2 (en) | 2014-12-30 | 2020-02-04 | Smith & Nephew, Inc. | Blockage detection in reduced pressure therapy |
DK3288508T3 (en) | 2015-04-27 | 2020-03-09 | Smith & Nephew | REDUCED PRESSURE DEVICES |
WO2016176513A1 (en) | 2015-04-29 | 2016-11-03 | Smith & Nephew Inc. | Negative pressure wound closure device |
US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
JP2019508124A (en) | 2016-02-12 | 2019-03-28 | スミス アンド ネフュー インコーポレイテッド | System and method for detecting operating conditions of decompression therapy |
JP1586115S (en) | 2016-02-29 | 2017-09-19 | ||
CN109069708B (en) | 2016-03-04 | 2022-04-12 | 史密夫及内修公开有限公司 | Negative pressure wound therapy device for wounds after breast surgery |
CN114053031A (en) | 2016-03-07 | 2022-02-18 | 史密夫及内修公开有限公司 | Wound therapy apparatus and method utilizing a negative pressure source integrated into a wound dressing |
US11167074B2 (en) * | 2016-03-17 | 2021-11-09 | Kcl Licensing, Inc. | Systems and methods for treating a tissue site using one manifold and multiple therapy units |
CA3022184A1 (en) | 2016-04-26 | 2017-11-02 | Smith & Nephew Plc | Wound dressings and methods of use with integrated negative pressure source having a fluid ingress inhibition component |
CN109069711A (en) | 2016-05-03 | 2018-12-21 | 史密夫及内修公开有限公司 | System and method for driving negative pressure source in negative pressure treatment system |
CA3038206A1 (en) | 2016-05-03 | 2017-11-09 | Smith & Nephew Plc | Optimizing power transfer to negative pressure sources in negative pressure therapy systems |
EP3452129B1 (en) | 2016-05-03 | 2022-03-23 | Smith & Nephew plc | Negative pressure wound therapy device activation and control |
AU2017261814B2 (en) | 2016-05-13 | 2022-05-19 | Smith & Nephew, Inc. | Automatic wound coupling detection in negative pressure wound therapy systems |
US11413388B2 (en) * | 2016-05-24 | 2022-08-16 | Somavac Medical Solutions, Inc. | Portable device with disposable reservoir for collection of internal fluid after surgery from a plurality of sites simultaneously |
CA3034789A1 (en) | 2016-08-25 | 2018-03-01 | Smith & Nephew Plc | Absorbent negative pressure wound therapy dressing |
AU2017336310B2 (en) | 2016-09-30 | 2022-12-08 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
US11282602B2 (en) * | 2016-10-26 | 2022-03-22 | Carefusion 2200, Inc. | Device and method for mobile monitoring of drainage catheter |
CN106581789B (en) * | 2016-12-12 | 2023-05-26 | 武汉维斯第医用科技股份有限公司 | External multi-pipeline converter for negative pressure closed drainage system |
CN110545765A (en) * | 2017-02-28 | 2019-12-06 | T.J.史密夫及内修有限公司 | Multi-dressing negative pressure wound treatment system |
WO2018162613A1 (en) | 2017-03-08 | 2018-09-13 | Smith & Nephew Plc | Negative pressure wound therapy device control in presence of fault condition |
AU2018234981B2 (en) | 2017-03-15 | 2023-09-28 | Smith & Nephew Plc | Multiple dressing negative pressure wound therapy system with calibrated leak paths |
US11471571B2 (en) | 2017-04-19 | 2022-10-18 | Smith & Nephew, Inc. | Negative pressure wound therapy canisters |
CN110612131B (en) | 2017-05-09 | 2023-05-16 | 史密夫及内修公开有限公司 | Redundant control for negative pressure wound therapy system |
AU2018331954A1 (en) | 2017-09-13 | 2020-03-19 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718070D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718054D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Sterilization of integrated negative pressure wound treatment apparatuses and sterilization methods |
GB201718072D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
EP3703632B1 (en) | 2017-11-01 | 2024-04-03 | Smith & Nephew plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
WO2019190753A1 (en) * | 2018-03-29 | 2019-10-03 | Kci Licensing, Inc. | A system for managing instillation therapy on multiple wounds with a single fluid source |
EP3823685B1 (en) * | 2018-07-16 | 2023-03-15 | KCI Licensing, Inc. | Wound therapy system with conduit blockage detection |
WO2020046410A1 (en) | 2018-08-29 | 2020-03-05 | Aatru Medical, LLC | Negative pressure treatment including mechanical and chemical pump |
USD898925S1 (en) | 2018-09-13 | 2020-10-13 | Smith & Nephew Plc | Medical dressing |
US11298268B2 (en) | 2018-09-19 | 2022-04-12 | Deroyal Industries, Inc. | Multiple-wound negative pressure wound therapy using multiple fluid collection volumes |
EP3893825A1 (en) | 2018-12-13 | 2021-10-20 | University of Massachusetts | Negative pressure wound closure devices and methods |
US11484640B2 (en) | 2019-07-03 | 2022-11-01 | T.J.Smith And Nephew, Limited | Negative pressure wound therapy dressing recognition, wound status detection, and therapy adjustment |
AU2022289651A1 (en) * | 2021-05-28 | 2023-12-14 | Zap Energy, Inc. | Electrode configuration for extended plasma confinement |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6135116A (en) * | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
US20030040687A1 (en) * | 2001-08-24 | 2003-02-27 | Kci Licensing, Inc | Vacuum assisted tissue treatment system |
US20040127863A1 (en) * | 2002-12-31 | 2004-07-01 | Bubb Stephen K. | Tissue closure treatment system, patient interface and method |
US20060025727A1 (en) * | 2003-09-16 | 2006-02-02 | Boehringer Laboratories, Inc. | Apparatus and method for suction-assisted wound healing |
US20070265586A1 (en) * | 2006-05-11 | 2007-11-15 | Joshi Ashok V | Device and method for wound therapy |
US20080200857A1 (en) * | 2007-02-20 | 2008-08-21 | Lawhorn Thomas P | System and method for distinguishing leaks from a disengaged canister condition in a reduced pressure treatment system |
US20090281509A1 (en) * | 2008-05-12 | 2009-11-12 | Gellis Michael B | Apparatus to collect body fluids following liposuction surgery |
US9364591B2 (en) * | 2010-11-17 | 2016-06-14 | Kci Licensing, Inc. | Systems and methods for managing reduced pressure at a plurality of wound sites |
Family Cites Families (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1355846A (en) | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US2547758A (en) | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US2969057A (en) | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
US3367332A (en) | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3682180A (en) | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3826254A (en) | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
DE2527706A1 (en) | 1975-06-21 | 1976-12-30 | Hanfried Dr Med Weigand | DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET |
DE2640413C3 (en) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Catheter monitor |
NL7710909A (en) | 1976-10-08 | 1978-04-11 | Smith & Nephew | COMPOSITE STRAPS. |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4080970A (en) | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4245637A (en) | 1978-07-10 | 1981-01-20 | Nichols Robert L | Shutoff valve sleeve |
SE414994B (en) | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
GB2047543B (en) | 1978-12-06 | 1983-04-20 | Svedman Paul | Device for treating tissues for example skin |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
US4284079A (en) | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
ATE14835T1 (en) | 1980-03-11 | 1985-08-15 | Schmid Eduard | SKIN GRAFT PRESSURE BANDAGE. |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4333468A (en) | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4465485A (en) | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
AU550575B2 (en) | 1981-08-07 | 1986-03-27 | Richard Christian Wright | Wound drainage device |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4525374A (en) | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
GB8419745D0 (en) | 1984-08-02 | 1984-09-05 | Smith & Nephew Ass | Wound dressing |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4826494A (en) | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4655754A (en) | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4605399A (en) | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US5037397A (en) | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US4640688A (en) | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
US4758220A (en) | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
EP0256060A1 (en) | 1986-01-31 | 1988-02-24 | OSMOND, Roger L. W. | Suction system for wound and gastro-intestinal drainage |
US4838883A (en) | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
JPS62281965A (en) | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
GB8621884D0 (en) | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
US4743232A (en) | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
GB8706116D0 (en) | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4985019A (en) | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US4919654A (en) | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
US5059596A (en) | 1989-01-16 | 1991-10-22 | Roussel Uclaf | Azabicyclo compounds |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5100396A (en) | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
US5134994A (en) | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5092858A (en) | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5278100A (en) | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5279550A (en) | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
FR2690617B1 (en) | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
DE4306478A1 (en) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainage device, in particular pleural drainage device, and drainage method |
US5342376A (en) | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
DE69505545T2 (en) | 1994-08-22 | 1999-03-11 | Kinetic Concepts Inc | WOUND DRAINAGE DEVICE |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | Mtg Medizinisch Tech Geraeteba | Electronically controlled low-vacuum pump for chest and wound drainage |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
EP1257313B1 (en) | 2000-02-24 | 2004-05-12 | Venetec International, Inc. | Universal catheter anchoring system |
JP2002065847A (en) * | 2000-06-14 | 2002-03-05 | Nextier:Kk | Inferior limb compressor used in dialysis |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
GB0325120D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
EP1800606B1 (en) * | 2004-10-14 | 2015-08-05 | Sumitomo Bakelite Company, Limited | Treatment instrument for coronary artery bypass operation |
CN101378794A (en) * | 2006-02-02 | 2009-03-04 | 科洛普拉斯特公司 | A suction method and a wound suction system |
DE102006051223B4 (en) * | 2006-04-25 | 2013-01-17 | Alfons Erdmann | Device for the treatment of patients suffering from skin lesions |
US8025650B2 (en) | 2006-06-12 | 2011-09-27 | Wound Care Technologies, Inc. | Negative pressure wound treatment device, and methods |
US20080041401A1 (en) | 2006-08-15 | 2008-02-21 | Casola Robert P | Computer adjusted pressure wound care devices, systems & methods |
US7967810B2 (en) * | 2006-10-20 | 2011-06-28 | Mary Beth Kelley | Sub-atmospheric wound-care system |
WO2008098207A2 (en) * | 2007-02-09 | 2008-08-14 | Twin Star Medical, Inc. | Method and system for the use of hollow fiber catheters in topical applications |
US8409170B2 (en) * | 2007-02-09 | 2013-04-02 | Kci Licensing, Inc. | System and method for managing reduced pressure at a tissue site |
US8021347B2 (en) | 2008-07-21 | 2011-09-20 | Tyco Healthcare Group Lp | Thin film wound dressing |
US8007481B2 (en) | 2008-07-17 | 2011-08-30 | Tyco Healthcare Group Lp | Subatmospheric pressure mechanism for wound therapy system |
CN102083478B (en) | 2008-05-21 | 2014-05-21 | 莫利斯·托帕斯 | Wound healing device |
US8251979B2 (en) | 2009-05-11 | 2012-08-28 | Tyco Healthcare Group Lp | Orientation independent canister for a negative pressure wound therapy device |
US8216198B2 (en) | 2009-01-09 | 2012-07-10 | Tyco Healthcare Group Lp | Canister for receiving wound exudate in a negative pressure therapy system |
US9847203B2 (en) * | 2010-10-14 | 2017-12-19 | Avx Corporation | Low current fuse |
-
2011
- 2011-11-09 US US13/292,926 patent/US9364591B2/en active Active
- 2011-11-09 CN CN201180052531.XA patent/CN103189080B/en active Active
- 2011-11-09 EP EP17194474.7A patent/EP3295971B1/en active Active
- 2011-11-09 EP EP19186548.4A patent/EP3574929B1/en active Active
- 2011-11-09 JP JP2013539904A patent/JP6114194B2/en active Active
- 2011-11-09 CA CA2814873A patent/CA2814873C/en active Active
- 2011-11-09 EP EP11784903.4A patent/EP2640436B1/en active Active
- 2011-11-09 EP EP16159093.0A patent/EP3053608B1/en active Active
- 2011-11-09 AU AU2011329273A patent/AU2011329273B2/en active Active
- 2011-11-09 WO PCT/US2011/060029 patent/WO2012067916A1/en active Application Filing
- 2011-11-17 TW TW100142128A patent/TW201225932A/en unknown
-
2016
- 2016-05-17 US US15/156,997 patent/US10940243B2/en active Active
-
2017
- 2017-03-16 JP JP2017050714A patent/JP6408052B2/en active Active
-
2021
- 2021-02-02 US US17/165,263 patent/US20210187172A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6135116A (en) * | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
US20030040687A1 (en) * | 2001-08-24 | 2003-02-27 | Kci Licensing, Inc | Vacuum assisted tissue treatment system |
US20040127863A1 (en) * | 2002-12-31 | 2004-07-01 | Bubb Stephen K. | Tissue closure treatment system, patient interface and method |
US20060025727A1 (en) * | 2003-09-16 | 2006-02-02 | Boehringer Laboratories, Inc. | Apparatus and method for suction-assisted wound healing |
US20070265586A1 (en) * | 2006-05-11 | 2007-11-15 | Joshi Ashok V | Device and method for wound therapy |
US20080200857A1 (en) * | 2007-02-20 | 2008-08-21 | Lawhorn Thomas P | System and method for distinguishing leaks from a disengaged canister condition in a reduced pressure treatment system |
US20090281509A1 (en) * | 2008-05-12 | 2009-11-12 | Gellis Michael B | Apparatus to collect body fluids following liposuction surgery |
US9364591B2 (en) * | 2010-11-17 | 2016-06-14 | Kci Licensing, Inc. | Systems and methods for managing reduced pressure at a plurality of wound sites |
US10940243B2 (en) * | 2010-11-17 | 2021-03-09 | Kci Licensing, Inc. | Systems and methods for managing reduced pressure at a plurality of wound sites |
Also Published As
Publication number | Publication date |
---|---|
JP2017127661A (en) | 2017-07-27 |
TW201225932A (en) | 2012-07-01 |
EP3295971B1 (en) | 2019-08-07 |
US10940243B2 (en) | 2021-03-09 |
EP3574929B1 (en) | 2023-06-07 |
EP3053608A1 (en) | 2016-08-10 |
US20160256614A1 (en) | 2016-09-08 |
CN103189080A (en) | 2013-07-03 |
EP3295971A1 (en) | 2018-03-21 |
JP6408052B2 (en) | 2018-10-17 |
US9364591B2 (en) | 2016-06-14 |
EP2640436B1 (en) | 2016-03-30 |
EP2640436A1 (en) | 2013-09-25 |
EP3574929A1 (en) | 2019-12-04 |
US20120123358A1 (en) | 2012-05-17 |
AU2011329273B2 (en) | 2016-04-28 |
AU2011329273A1 (en) | 2013-04-18 |
JP6114194B2 (en) | 2017-04-12 |
EP3053608B1 (en) | 2017-10-18 |
WO2012067916A1 (en) | 2012-05-24 |
CA2814873C (en) | 2018-04-24 |
JP2014501561A (en) | 2014-01-23 |
CN103189080B (en) | 2016-01-06 |
CA2814873A1 (en) | 2012-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210187172A1 (en) | Systems and methods for managing reduced pressure at a plurality of wound sites | |
US10773000B2 (en) | Wound connection pad with pneumatic connection confirmation ability | |
US20200155736A1 (en) | Systems and methods for treating a tissue site with reduced pressure involving a reduced-pressure interface having a cutting element | |
US10556044B2 (en) | Reduced-pressure dressing connection pads, systems, and methods | |
US11925747B2 (en) | Dressing interface with micro-needles for negative-pressure treatment | |
WO2023166394A1 (en) | Apparatuses, kits, and methods for tissue interface placement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KCI LICENSING, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HALL, COLIN JOHN;LOCKE, CHRISTOPHER BRIAN;REEL/FRAME:055114/0118 Effective date: 20111021 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |